Xuxiang Wang
4PUBLICATIONS
18CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Mar 24, 2025
Genome-wide CRISPR activation screen identifies ARL11 as a sensitivity determinant of PARP inhibitor therapy.Tengjiang Zhang, Yuan Zhang, Xuxiang Wang
|Mar 13, 2025
Targeting both death and paracaspase domains of MALT1 with antisense oligonucleotides overcomes resistance to immune-checkpoint inhibitors.Yuwei Tao, Chen Tian, Shaolong Qi
|Aug 15, 2024
Lymphotoxin-β promotes breast cancer bone metastasis colonization and osteolytic outgrowth.Xuxiang Wang, Tengjiang Zhang, Bingxin Zheng
|Dec 01, 2023
Osteoclast Cancer Cell Metabolic Cross-talk Confers PARP Inhibitor Resistance in Bone Metastatic Breast Cancer.Huijuan Fan, Zhanao Xu, Ke Yao
Pageof 1
Frequent Collaborators
4 joint publications
Tengjiang Zhang
4 joint publications
Haitian Hu
4 joint publications
Hanqiu Zheng
2 joint publications
Bingxin Zheng
2 joint publications
Xun Lan
2 joint publications
Bin Yue
2 joint publications
Guoyuan Xu
1 joint publications
Huijuan Fan
1 joint publications
Zhanao Xu
1 joint publications
Jiaqi Liu
